IUF - LEIBNIZ-INSTITUT FUR UMWELTMEDIZINISCHE FORSCHUNG GMBH

Their core work

IUF is a Leibniz research institute in Düsseldorf specializing in environmental health — how chemical exposures, air pollution, and nanoparticles affect human biology, particularly the brain and nervous system. Their core work spans toxicology testing (both in vitro and in vivo), endocrine disruptor research, and developing animal-free methods to predict chemical hazards. They bridge the gap between environmental exposure science and regulatory safety assessment, providing the mechanistic understanding needed to evaluate whether chemicals and nanomaterials are safe for humans.

What they specialise in

How they've shifted over time

IUF's early H2020 work (2018-2019) centered on classical toxicology concerns — endocrine disrupting chemicals, developmental neurotoxicity, and building better in vitro assays with omics endpoints and adverse outcome pathways. By 2021, their focus shifted decisively toward computational and AI-based approaches: ontology-driven toxicity prediction, animal-free testing methodologies, and next-generation risk assessment frameworks. The trajectory shows a research group moving from generating experimental toxicology data toward building predictive systems that could replace animal testing altogether.

IUF is moving from experimental toxicology toward computational and AI-based chemical safety prediction — expect future work at the intersection of machine learning, regulatory science, and alternative testing methods.

How they like to work

IUF operates exclusively as a participant, never as coordinator, suggesting they contribute deep specialist expertise to consortia rather than managing them. With 71 unique partners across 21 countries from just 4 projects, they work in large, well-funded research consortia — averaging nearly 18 partners per project. This pattern indicates an organization valued for its specific scientific capabilities that gets invited into major European initiatives by coordinators who need toxicology expertise.

Despite only 4 projects, IUF has built an extensive network of 71 partners across 21 countries, reflecting participation in large pan-European consortia. Their reach spans most of the EU, with no apparent geographic concentration beyond their German base.

What sets them apart

IUF occupies a rare niche at the intersection of environmental medicine, regulatory toxicology, and computational prediction — few institutes combine wet-lab toxicology expertise with AI-driven hazard assessment. As a Leibniz institute, they carry institutional credibility and long-term research continuity that project-dependent groups cannot match. For consortium builders, IUF offers a partner that can contribute both traditional experimental toxicology and the increasingly demanded animal-free, computationally-driven approaches that EU regulation is moving toward.

Highlights from their portfolio

• ONTOX
  Their largest funded project (EUR 975K) and most forward-looking — combines AI, ontology, and animal-free methods for chemical risk assessment, running until 2026.
• ENDpoiNTs
  Highest single funding (EUR 1.07M) and directly aligned with EU regulatory priorities on endocrine disruptors and developmental neurotoxicity testing.
• TUBE
  Unusual cross-sector project linking transport-derived air pollution to brain diseases including Alzheimer's — connects environmental exposure to neurodegeneration.